Erratum

doi: 10.1097/BRS.0000000000004450

Metrics

In the January 15, 2022 issue of Spine in the article by Sardar et al, “Best Practice Guidelines for Assessment and Management of Osteoporosis in Adult Patients Undergoing Elective Spinal Reconstruction”, Appendix A was cited in the text; however, there was no link provided for Appendix A in the article. The online version of this article has been corrected. Also, the following sentence was added to the Discussion section, second-to-last paragraph: “Romosozumab is a monoclonal antibody that acts as an anabolic agent by inhibiting sclerostin.”

Sardar ZM, Coury JR, Cerpa M, et al. Best practice guidelines for assessment and management of osteoporosis in adult patients undergoing elective spinal reconstruction. Spine. 2022;47:128–35. © 2022 Wolters Kluwer Health, Inc. All rights reserved.